Director HCP Marketing
Ipsen Global
Director HCP Marketing
Ipsen Global
Global biopharma focused on specialty care
Title:
Director, HCP Marketing, Dysport MigraineCompany:
Ipsen Biopharmaceuticals Inc.About Ipsen:
Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.
Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society!
For more information, visit us at https://www.ipsen.com/ and follow our latest news on LinkedIn and Instagram.
Job Description:
The Director, HCP Marketing, Dysport Migraine is a new, key strategic role in the Neuroscience Business Unit, US. This is a unique opportunity to shape the future of Dysport in a new therapeutic area and make a meaningful impact for patients living with migraine. You will be part of a passionate, collaborative team committed to innovation and excellence in Neuroscience.
The Director will lead all HCP marketing efforts for the potential migraine indication expansion for Dysport. The position will report to the Senior Director, Brand Lead – Dysport Migraine.
We are seeking a candidate with a strong background in the US launch of migraine or related specialty neuroscience therapeutics, and preferably with neuroxin experience in the space. The ability to drive for success through a cross-functional approach to launch, and the ability to succeed in a fast-paced environment are essential.
The role will be responsible for developing, managing, and ultimately executing all HCP-facing elements of the launch This includes all facets of launch readiness planning, including but not limited to strategy, positioning, segmentation, messaging, asset development, conference planning/execution, and budget planning/management.
The successful candidate will be responsible for collaborating with cross-functional partners including tbe Global Launch Team, Data & Analytics, Insights, Sales, Medical Affairs, Regulatory and Legal. Additionally, the role will lead the relationships with external partners, including creative & other agency partners.
Main Responsibilities & Technical Competencies
This role is critical to shaping the brand’s entry into the migraine space and will key in the development and execution of a comprehensive patient marketing strategy that positions Dysport for success in a competitive and evolving market.
Behavioral Competencies Required
Drive Vision and Strategy
This role is responsible for shaping the launch strategy for Dysport in a new therapeutic area, requiring strategic foresight and the ability to inspire alignment across stakeholders.
Customer (& Patient) Focus
The role involves developing patient marketing strategies and ensuring the brand resonates with patient needs and experiences.
Collaborates
The role requires extensive cross-functional collaboration across internal teams and external agencies to ensure launch success.
Excellence in Execution
The role demands strong executional capabilities to manage launch readiness, campaign development, and performance tracking.
Influences
The role requires influencing diverse stakeholders across a matrixed organization and external partners to align on strategy and execution.
HOW - Knowledge & Experience
Knowledge & Experience (essential):
Knowledge & Experience (preferred):
Education / Certifications (essential):
Education / Certifications (essential):
Compensation
Global biopharma focused on specialty care
Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.
Explore more opportunities at Ipsen Global